Retatrutide is a newly developed therapy that acts as a strong GLP-1 receptor agonist. This innovative method holds significant potential for controlling type 2 diabetes. By imitating the actions of natural GLP-1, Retatrutide improves insulin secretion and suppresses glucagon release, leading to improved glycemic control. Clinical trials have demon